Another study addressing 10 ALS-TDP patients reported that tau aggregation was observed in the entorhinal cortex of all assayed patients, and ALS patients with cognitive impairment showed a broader extension of neuronal and glial tau pathology than those without cognitive impairment [82]. The gene discussed is MAPT; the disease is Cognitive impairment.